KRAS and colorectal carcinoma: Moreover, since M2-PK is the direct target of several oncoproteins including K-ras [71], detection of faceal M2-PK has been suggested to be a more sensitive screening tool for CRC than detection of mutations in the oncogenes themselves [72].